SCHEMBL10286134

SCHEMBL10286134

Cc1cc(N2CCCCC2)c2c(n1)C(O)CCCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.42
GBA1 P04062 1/20 0.37
KDM4E B2RXH2 7/20 0.37
HSD17B10 Q99714 6/20 0.37
ALDH1A1 P00352 5/20 0.37
HPGD P15428 4/20 0.37
RECQL P46063 1/20 0.37
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPY5R Q15761 1/20 0.36
NPSR1 Q6W5P4 3/20 0.34
ACHE P22303 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
APP P05067 1/20 0.34
BCHE P06276 1/20 0.34
UGT2B17 O75795 2/20 0.34
USP2 O75604 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10286186 0.99 NCF1 (0.40) NCF1GBA1KDM4EHSD17B10ALDH1A1
SCHEMBL527090 0.94 NCF1 (0.40) NCF1GBA1KDM4EHSD17B10ALDH1A1
SCHEMBL10286133 0.81 ACHE (0.36) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL10286333 0.79 UGT2B17 (0.45) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL10286315 0.79 ACHE (0.39) ACHEUGT2B17
SCHEMBL10286091 0.78 HCRTR1 (0.38) KDM4EHSD17B10ALDH1A1ACHEUGT2B17
SCHEMBL10286084 0.77 KDM4E (0.36) KDM4EHSD17B10ALDH1A1HPGDLMNA
SCHEMBL10286275 0.77 ACHE (0.40) KDM4EHSD17B10ALDH1A1SMN1; SMN2ACHE
SCHEMBL10287369 0.76 ACHE (0.36) GBA1ACHEUGT2B17GRM2
SCHEMBL10286085 0.76 ACHE (0.43) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
WO-2012001040-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES MSR1, DDT, MPO NCF1 719/4885GBA1 768/4885KDM4E 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.